Clinical and Economic Impact of a Tri-Layer Hybrid Biomaterial vs Synthetic Mesh for Ventral Hernia Repair in Australia: A Cost-Consequence and Budget Impact Analysis

Speaker(s)

Imhoff R, Marti A, Landaas E
W. L. Gore & Associates, Inc., Flagstaff, AZ, USA

OBJECTIVES: Assess the economic benefits of the tri-layer hybrid biomaterial (THB) versus a synthetic mesh (SM), placed in the preperitoneal plane, by comparing clinical outcomes, resource use and the budget impact when repairing ventral-incisional hernias.

METHODS: Cost-consequence and budget impact analyses were derived from patient outcomes identified for each device through a targeted literature review. Patient outcomes were measured at 3 years post-implant: reoperation due to hernia recurrence, development of seroma (stratified by treatment to resolve), mesh explant due to infection, and median hospital length of stay. Costs (in AUD) to the Australian health care system were obtained from public sources. Results were confirmed with one-way and probabilistic sensitivity analyses.

RESULTS: There was no reported reoperation for hernia recurrence among THB patients, compared to 9.8% among SM patients. The seroma rate was also lower for THB, with fewer requiring intervention or reoperation to resolve. This led to an expected cost savings of $946 per patient treated when using the THB, resulting in a projected budget impact of $23.85 million in savings to the Australian NHS if 100% of patients used THB. Incorporating reduced LOS (4 days for SM versus 1 day for THB) increases the expected cost savings to $3,001 per patient treated, and a budget impact of $75.7 million in savings. Sensitivity analyses showed results to be robust to reasonable changes in base input values. The cost savings were driven largely by a lower rate of reoperation due to hernia recurrence.

CONCLUSIONS: The findings of this study suggest that using the tri-layer hybrid biomaterial may improve patient outcomes, lower reintervention rates, and result in substantial cost savings for the Australia health system, compared to using a synthetic mesh. Additional cost-effectiveness modeling, highlighting potential quality of life benefits, will provide further insights on the benefits of the THB.

Code

EE729

Topic

Clinical Outcomes, Economic Evaluation, Medical Technologies

Topic Subcategory

Budget Impact Analysis, Comparative Effectiveness or Efficacy, Cost-comparison, Effectiveness, Utility, Benefit Analysis, Medical Devices

Disease

Medical Devices, Surgery